Reglan (Generic: Metoclopramide) is a drug prescribed for acid reflux disease. Reglan has been linked with Tardive Dyskinesia and Neuroleptic Malignant Syndrome. Both of these conditions are very serious and Neuroleptic Malignant Syndrome is often fatal. Reglan is most commonly prescribed to patients suffering from gastroesophageal reflux, (Gerd; Heartburn; Acid Reflux Disease). The FDA has approved the drug for short-term use (4 to 12 weeks) and only when conservative treatment fails. While the FDA has approved Reglan only for short-term use, approximately 1/3 of patients are being prescribed the medication for 12 months or greater.

Long-term use can cause serious side effects including Tardive Dyskinesia, a neurological disorder which causes involuntary movements of the tongue, mouth, face, lips and sometimes arms, trunk or legs. The warning label for Reglan (Metoclopramide) mentions tardive dyskinesia, but suggests that it occurs rarely. Two studies have determined the prevalence of Tardive Dyskinesia to be between 27 percent and 29 percent in long-term users.

Reglan has also been linked to Neuroleptic Malignant Syndrome (NMS). Neuroleptic Malignant Syndrome is normally associated with antipsychotic drugs.  It is an extremely serious syndrome that usually creates a neurological emergency.  Most patients develop Neuroleptic Malignant Syndrome shortly after initial exposure to a drug. Neuroleptic Malignant Syndrome symptoms include high fever, sweating, unstable blood pressure, stupor, muscular rigidity, and autonomic dysfunction.  In most cases, the disorder develops within the first 2 weeks of treatment with the drug; however, the disorder may develop any time during the therapy period.

If you or a loved one took Reglan and suffered side effects, please CONTACT US through this web site or all us TOLL FREE.